The Impact of Hormonal Contraceptive Use on Serotonergic Neurotransmission and Antidepressant Treatment Response: Results From the NeuroPharm 1 Study

The Impact of Hormonal Contraceptive Use on Serotonergic Neurotransmission and Antidepressant Treatment Response: Results From the NeuroPharm 1 Study

BackgroundHormonal contraceptive (HC) use has been associated with an increased risk of developing a depressive episode. This might be related to HC’s effect on the serotonergic brain system as suggested by recent cross-sectional data from our group, which show that healthy oral contraceptive (OC) u...

Full description

Bibliographic Details
Main Authors:	Søren Vinther Larsen, Brice Ozenne, Kristin Köhler-Forsberg, Asbjørn Seenithamby Poulsen, Vibeke Høyrup Dam, Claus Svarer, Gitte Moos Knudsen, Martin Balslev Jørgensen, Vibe Gedso Frokjaer
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-03-01
Series:	Frontiers in Endocrinology
Subjects:	hormonal contraception oral contraception hormonal intrauterine device [11C]SB207145 serotonin major depressive disorder
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2022.799675/full

Similar Items

Evaluating cognitive disturbances as treatment target and predictor of antidepressant action in major depressive disorder: A NeuroPharm study
by: Vibeke Høyrup Dam, et al.
Published: (2022-11-01)

Sexual health and serotonin 4 receptor brain binding in unmedicated patients with depression—a NeuroPharm study
by: Annika Læbo Rasmussen, et al.
Published: (2023-07-01)

Stress-Hormone Dynamics and Working Memory in Healthy Women Who Use Oral Contraceptives Versus Non-Users
by: Emma Sofie Høgsted, et al.
Published: (2021-11-01)

Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial Protocol
by: Kristin Köhler-Forsberg, et al.
Published: (2020-07-01)

Concurrent anxiety in patients with major depression and cerebral serotonin 4 receptor binding. A NeuroPharm-1 study
by: Kristin Köhler-Forsberg, et al.
Published: (2022-07-01)

Effects of an Oral Contraceptive on Dynamic Brain States and Network Modularity in a Serial Single-Subject Study
by: Kristian Høj Reveles Jensen, et al.
Published: (2022-06-01)

Generalizability of treatment outcome prediction in major depressive disorder using structural MRI: A NeuroPharm study
by: Vincent Beliveau, et al.
Published: (2022-01-01)

Psychometric Properties of the Verbal Affective Memory Test-26 and Evaluation of Affective Biases in Major Depressive Disorder
by: Liv V. Hjordt, et al.
Published: (2020-06-01)

Systemic DNA and RNA damage from oxidation after serotonergic treatment of unipolar depression
by: Anders Jorgensen, et al.
Published: (2022-05-01)

Functional and molecular neuroimaging of menopause and hormone replacement therapy
by: Erika eComasco, et al.
Published: (2014-12-01)

Deep phenotyping towards precision psychiatry of first-episode depression — the Brain Drugs-Depression cohort
by: Kristian Høj Reveles Jensen, et al.
Published: (2023-03-01)

Association between brain serotonin 4 receptor binding and reactivity to emotional faces in depressed and healthy individuals
by: Anjali Sankar, et al.
Published: (2023-05-01)

EXAMINATION OF SOME HAEMATOLOGIC AND CHEMICAL INDICES IN WOMEN TAKING HORMONAL CONTRACEPTIVE OR USING AN INTRA-UTERINE DEVICES
by: A.Majd, et al.
Published: (1973-07-01)

EXAMINATION OF SOME HAEMATOLOGIC AND CHEMICAL INDICES IN WOMEN TAKING HORMONAL CONTRACEPTIVE OR USING AN INTRA-UTERINE DEVICES
by: A.Majd, et al.
Published: (1973-03-01)

Prevalence and Self-Perceived Experiences With the Use of Hormonal Contraceptives Among Competitive Female Cross-Country Skiers and Biathletes in Norway: The FENDURA Project
by: Tina P. Engseth, et al.
Published: (2022-04-01)

Associations between the cortisol awakening response and patient-evaluated stress and mood instability in patients with bipolar disorder: an exploratory study
by: Maria Faurholt-Jepsen, et al.
Published: (2021-03-01)

OVERCOME BARRIERS IN PRESCRIPTION OF HORMONAL CONTRACEPTION (CLINICAL LECTURE)
by: O. A. Pustotina, et al.
Published: (2016-12-01)

Genetic contributions to brain serotonin transporter levels in healthy adults
by: Silvia Elisabetta Portis Bruzzone, et al.
Published: (2023-09-01)

Hormonal Contraception Use and Depression Among Women in Saudi Arabia
by: Albawardi I, et al.
Published: (2022-08-01)

Emergency Contraception Access and Counseling in Urban Pharmacies: A Comparison between States with and without Pharmacist Prescribing
by: Rebecca H. Stone, et al.
Published: (2020-06-01)

Perbandingan Kepadatan Mineral Tulang Antar Pemakai Kontrasepsi Hormonal Progestin dan Kontrasepsi Non Hormonal pada Wanita Usia Subur
by: Aprilina Aprilina, et al.
Published: (2020-05-01)

Knowledge, Attitude and Practice Regarding Hormonal Emergency Contraception Aamong Married Female Staff in Universiti Putra Malaysia
by: Sharj Abad, Fatemeh Najafi
Published: (2010)

Hormonal contraception and thrombosis: Identifying the gaps in knowledge among females in post-secondary education
by: Skylar Tierney, et al.
Published: (2023-04-01)

Emergency contraception: ¿how, when and with what?
by: Álvaro Monterrosa Castro
Published: (2006-04-01)

Male contraception
by: Vivek Mathew, et al.
Published: (2012-01-01)

The use, knowledge and attitudes regarding hormonal contraceptive products of female first-year students in a Faculty of Health Sciences
by: P. M. van Zyl, et al.
Published: (2019-10-01)

What is the current status of emergency Contraception?
by: Rincón-Niño Erika Tatiana, et al.
Published: (2010-12-01)

Beyond Contraception: The Medical Necessity of Hormonal Contraceptives for Optimal Health and Well-being of Women in the UAE
by: Shamsa Al Awar, et al.
Published: (2024-01-01)

Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH)
by: Simona Sacco, et al.
Published: (2018-08-01)

Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)
by: Simona Sacco, et al.
Published: (2017-10-01)

Comparison of Combined Parenteral and Oral Hormonal Contraceptives: A Systematic Review and Meta-Analysis of Randomized Trials
by: Gábor Vleskó, et al.
Published: (2024-01-01)

Estetrol: a new estrogen component in combined oral contraceptives: A review
by: Aida U. Hamadyanova, et al.
Published: (2023-01-01)

Neuroprotective effects of estetrol in combined oral contraceptives: A review
by: Mekan R. Orazov, et al.
Published: (2023-07-01)

NEW MODE OF PROLONGED HORMONAL CONTRACEPTION
by: A. N. Mheryan, et al.
Published: (2017-10-01)

Knowledge and attitudes about oral hormonal contraception among students from selected universities
by: Agata Anusiewicz, et al.
Published: (2022-05-01)

Health benefits of hormonal contraception used by symptoms associated with acne vulgaris and hirsutism
by: Anna Sobstyl, et al.
Published: (2019-09-01)

INJECTION HORMONIC CONTRACEPTION FOR WOMEN
by: Milena Veljković
Published: (2004-01-01)

Health benefits of hormonal contraception used by symptoms associated with acne vulgaris and hirsutism
by: Anna Sobstyl, et al.
Published: (2019-09-01)

Development of a pharmacoeconomic registry: an example using hormonal contraceptives
by: Annesha White, et al.
Published: (2021-03-01)

CONTRACEPTIVE AGENTS USED IN BITCHES AND CATS
by: A. L. M. Marinho, et al.
Published: (2016-02-01)